[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100530911":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":26,"responsibleParty":42,"collaborators":7,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":52,"maxAge":7,"enrollmentInfo":53,"targetDuration":7,"studyType":56,"phases":7,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Centre Hospitalier Sud Francilien","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"BEHAVIORAL","Counseling home caregivers","Advice on the proper use of insulin therapy will be given, if necessary, to caregivers. Patients are reviewed at 1 month of this first visit with a collection of the same data",[14],{"name":15,"affiliation":5,"role":16},"Marie BOULY, APN","PRINCIPAL_INVESTIGATOR",[18,22],{"name":15,"role":19,"phone":20,"phoneExt":7,"email":21},"CONTACT","01 61 69 35 93","marie.bouly@chsf.fr",{"name":23,"role":19,"phone":24,"phoneExt":7,"email":25},"Caroline TOURTE","01 61 69 31 50","caroline.tourte@chsf.fr",[27],{"facility":5,"status":28,"city":29,"state":30,"zip":31,"country":30,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Corbeil-Essonnes","France","91106","FR",{"type":34,"coordinates":35},"Point",[36,37],2.48757,48.60603,{"lat":37,"lon":36},[40],{"name":41,"role":19,"phone":20,"phoneExt":7,"email":21},"Marie BOULY",{"type":43,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100530911","impact-of-smart-connected-insulin-pens-on-quality-of-life-in-dependent-patients-with-diabetes-using-continuous-glucose-measurement-100530911",false,"NCT06192940","Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement","BESTYLCO","Inclusion Criteria:\n\n* Older than 18 years patient with type 1 or 2 diabetes\n* Treated with multiple insulin injections\n* Equipped with a continuous glucose measurement system and smart connected insulin pens at least one month before\n* Dependent on a health professional for treatment management.\n* Subject informed of the study and not objecting to data collection.\n\nExclusion Criteria:\n\n\\- Patient refusing study.","ALL","18 Years",{"count":54,"type":55},30,"ESTIMATED","OBSERVATIONAL","Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected insulin pens and continuous glucose measurement can improve insulin therapy practice in dependent and\u002For institutionalized patients?",[59],"Diabetes",[61,62,63],"insulin practice","Dependent patient","Smart connected insulin pen","2025-03-12",{"date":66,"type":67},"2025-03-14","ACTUAL",{"date":69,"type":67},"2024-03-28",{"date":71,"type":55},"2025-12-31",{"name":5,"class":6},1]